CA2418162A1 - Use of il-8 receptor antagonists in the treatment of virus infections - Google Patents
Use of il-8 receptor antagonists in the treatment of virus infections Download PDFInfo
- Publication number
- CA2418162A1 CA2418162A1 CA002418162A CA2418162A CA2418162A1 CA 2418162 A1 CA2418162 A1 CA 2418162A1 CA 002418162 A CA002418162 A CA 002418162A CA 2418162 A CA2418162 A CA 2418162A CA 2418162 A1 CA2418162 A1 CA 2418162A1
- Authority
- CA
- Canada
- Prior art keywords
- viral infection
- human
- respiratory viral
- therapeutic agent
- respiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21905300P | 2000-07-18 | 2000-07-18 | |
US60/219,053 | 2000-07-18 | ||
PCT/US2001/022328 WO2002005814A1 (en) | 2000-07-18 | 2001-07-16 | Use of il-8 receptor antagonists in the treatment of virus infections |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2418162A1 true CA2418162A1 (en) | 2002-01-24 |
Family
ID=22817645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002418162A Abandoned CA2418162A1 (en) | 2000-07-18 | 2001-07-16 | Use of il-8 receptor antagonists in the treatment of virus infections |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1307190A4 (es) |
JP (1) | JP2004509852A (es) |
KR (1) | KR20030019587A (es) |
CN (1) | CN1449285A (es) |
AR (1) | AR033830A1 (es) |
AU (1) | AU2001273497A1 (es) |
BR (1) | BR0112603A (es) |
CA (1) | CA2418162A1 (es) |
CZ (1) | CZ2003132A3 (es) |
HU (1) | HUP0300754A3 (es) |
IL (1) | IL153921A0 (es) |
MX (1) | MXPA03000500A (es) |
NO (1) | NO20030201L (es) |
NZ (1) | NZ523659A (es) |
PL (1) | PL365886A1 (es) |
WO (1) | WO2002005814A1 (es) |
ZA (1) | ZA200300474B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008509143A (ja) * | 2004-08-04 | 2008-03-27 | シェーリング コーポレイション | 気道疾患の処置のためのプレコナリルを含む薬学的処方物 |
PE20170185A1 (es) * | 2014-05-12 | 2017-04-01 | Glaxosmithkline Intellectual Property (No 2) Ltd | Composiciones farmaceuticas para tratar enfermedades infecciosas |
BR112022018294A2 (pt) * | 2020-03-26 | 2023-01-10 | Dompe Farm Spa | Inibidores de cxcl8 para uso no tratamento de covid-19 |
EP3884932A1 (en) * | 2020-03-26 | 2021-09-29 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
EP4008325A1 (en) * | 2020-12-02 | 2022-06-08 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5547979A (en) * | 1992-03-30 | 1996-08-20 | Smithkline Beecham | TNF inhibition |
WO1996005836A2 (en) * | 1994-08-25 | 1996-02-29 | Medical University Of South Carolina | Methods of treating cold symptoms using pentoxifylline |
JPH11503110A (ja) * | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | Il−8受容体拮抗剤 |
SE9802729D0 (sv) * | 1998-08-13 | 1998-08-13 | Astra Pharma Prod | Novel Compounds |
SE9802937D0 (sv) * | 1998-09-01 | 1998-09-01 | Astra Pharma Prod | Novel compounds |
-
2001
- 2001-07-16 BR BR0112603-2A patent/BR0112603A/pt not_active IP Right Cessation
- 2001-07-16 IL IL15392101A patent/IL153921A0/xx unknown
- 2001-07-16 AR ARP010103395A patent/AR033830A1/es not_active Application Discontinuation
- 2001-07-16 CZ CZ2003132A patent/CZ2003132A3/cs unknown
- 2001-07-16 MX MXPA03000500A patent/MXPA03000500A/es unknown
- 2001-07-16 CA CA002418162A patent/CA2418162A1/en not_active Abandoned
- 2001-07-16 NZ NZ523659A patent/NZ523659A/en unknown
- 2001-07-16 KR KR10-2003-7000717A patent/KR20030019587A/ko not_active Application Discontinuation
- 2001-07-16 EP EP01952777A patent/EP1307190A4/en not_active Withdrawn
- 2001-07-16 AU AU2001273497A patent/AU2001273497A1/en not_active Abandoned
- 2001-07-16 WO PCT/US2001/022328 patent/WO2002005814A1/en active Application Filing
- 2001-07-16 HU HU0300754A patent/HUP0300754A3/hu unknown
- 2001-07-16 JP JP2002511746A patent/JP2004509852A/ja not_active Withdrawn
- 2001-07-16 CN CN01813095A patent/CN1449285A/zh active Pending
- 2001-07-16 PL PL01365886A patent/PL365886A1/xx not_active Application Discontinuation
-
2003
- 2003-01-15 NO NO20030201A patent/NO20030201L/no not_active Application Discontinuation
- 2003-01-17 ZA ZA200300474A patent/ZA200300474B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20030019587A (ko) | 2003-03-06 |
CZ2003132A3 (cs) | 2003-09-17 |
ZA200300474B (en) | 2004-08-17 |
WO2002005814A1 (en) | 2002-01-24 |
AU2001273497A1 (en) | 2002-01-30 |
BR0112603A (pt) | 2004-08-24 |
HUP0300754A3 (en) | 2009-03-02 |
PL365886A1 (en) | 2005-01-10 |
NZ523659A (en) | 2006-01-27 |
MXPA03000500A (es) | 2003-06-24 |
JP2004509852A (ja) | 2004-04-02 |
NO20030201D0 (no) | 2003-01-15 |
EP1307190A1 (en) | 2003-05-07 |
IL153921A0 (en) | 2003-07-31 |
HUP0300754A2 (hu) | 2003-08-28 |
NO20030201L (no) | 2003-03-17 |
CN1449285A (zh) | 2003-10-15 |
EP1307190A4 (en) | 2007-08-22 |
AR033830A1 (es) | 2004-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU763573B2 (en) | Thiadiazolyl urea or thiourea derivatives for antiviral treatment | |
JP2656938B2 (ja) | dsRNAと逆転写酵素インヒビターを含んで成るHIV感染治療のための医薬組成物 | |
EP0509019B1 (en) | Treatment of human retroviral infections with 2',3'-dideoxyinosine | |
US7863242B2 (en) | Compositions for down-regulation of CCR5 expression and methods of use thereof | |
Johnson et al. | Three-Drug Synergistic Inhibition of HIV-l Replication In Vitro by Zidovudine, Recombinant Soluble CD4, and Recombinant Interferon-alpha A | |
US6214881B1 (en) | IL-8 receptor antagonists | |
JP3306830B2 (ja) | レトロウイルスインテグラーゼの阻害剤 | |
WO1994004145A1 (en) | Treatment of human viral infections | |
US20040038854A1 (en) | Use of il-8 receptor antagonists in the treatment of virus infections | |
AU763431B2 (en) | Viral treatment | |
CA2418162A1 (en) | Use of il-8 receptor antagonists in the treatment of virus infections | |
US20040022762A1 (en) | Use of il-8 protein modulators in the treatment of viral infections | |
WO2005000231A2 (en) | Il-8 receptor antagonists | |
EP1180028B1 (en) | Il-8 receptor antagonists | |
AU5616100A (en) | Il-8 receptor antagonists | |
US6248785B1 (en) | IL-8 receptor antagonists | |
JPH01132526A (ja) | 薬剤組成物 | |
JP2004083576A (ja) | Hiv感受性株に対して活性をもち、ヌクレオシド系ならびに非ヌクレオシド系の逆転写酵素阻害剤、およびプロテアーゼ阻害剤に対し抵抗性のhiv株に対して活性をもつ抗レトロウイルス治療薬を得るための、クロロキン、ヒドロキシクロロキン、および4アミノ−キノリン酸誘導体の使用 | |
AU767000B2 (en) | IL-8 receptor antagonists | |
WO1989011860A1 (en) | Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection | |
Foxworth | Toxicities of antimicrobial agents used in the intensive care arena | |
JPH07508998A (ja) | 抗ウイルス剤の組み合わせ | |
MXPA01009889A (es) | Derivados de tiadiazolil urea o tiourea para tratamiento antiviral | |
MXPA00002283A (es) | Antagonistas de receptor il-8 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |